{
  "actions": [
    {
      "acted_at": "2021-04-28",
      "action_code": "10000",
      "references": [],
      "text": "Introduced in Senate",
      "type": "action"
    },
    {
      "acted_at": "2021-04-28",
      "action_code": "",
      "committees": [
        "SSFI"
      ],
      "references": [],
      "status": "REFERRED",
      "text": "Read twice and referred to the Committee on Finance.",
      "type": "referral"
    }
  ],
  "amendments": [],
  "bill_id": "s1427-117",
  "bill_type": "s",
  "by_request": false,
  "committee_reports": [],
  "committees": [
    {
      "activity": [
        "referral"
      ],
      "committee": "Senate Finance",
      "committee_id": "SSFI"
    }
  ],
  "congress": "117",
  "cosponsors": [
    {
      "bioguide_id": "B001267",
      "district": null,
      "name": "Bennet, Michael F.",
      "original_cosponsor": true,
      "sponsored_at": "2021-04-28",
      "state": "CO",
      "title": "Sen.",
      "withdrawn_at": null
    }
  ],
  "enacted_as": null,
  "history": {
    "active": false,
    "awaiting_signature": false,
    "enacted": false,
    "vetoed": false
  },
  "introduced_at": "2021-04-28",
  "number": "1427",
  "official_title": "A bill to establish a demonstration project to increase access to biosimilar biological products under the Medicare program.",
  "popular_title": null,
  "related_bills": [
    {
      "bill_id": "hr2869-117",
      "identified_by": "CRS",
      "reason": "related",
      "type": "bill"
    }
  ],
  "short_title": "Increasing Access to Biosimilars Act of 2021",
  "sponsor": {
    "bioguide_id": "C001056",
    "district": null,
    "name": "Cornyn, John",
    "state": "TX",
    "title": "Sen.",
    "type": "person"
  },
  "status": "REFERRED",
  "status_at": "2021-04-28",
  "subjects": [
    "Congressional oversight",
    "Government studies and investigations",
    "Health",
    "Health care costs and insurance",
    "Health information and medical records",
    "Health programs administration and funding",
    "Medicare",
    "Prescription drugs"
  ],
  "subjects_top_term": "Health",
  "summary": {
    "as": "Introduced in Senate",
    "asOf": "2021-04-28",
    "date": "2021-06-15T16:16:25Z",
    "text": "Increasing Access to Biosimilars Act of 2021\n\nThis bill requires the Centers for Medicare & Medicaid Services to establish a demonstration project to evaluate the benefits of providing additional payments to providers of biosimilars under Medicare. Specifically, under the demonstration project, participating providers receive an additional payment based on the difference between the costs to the provider of furnishing the biosimilar and the cost if the provider had furnished the underlying reference biological product instead."
  },
  "titles": [
    {
      "as": null,
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "Increasing Access to Biosimilars Act of 2021",
      "type": "display"
    },
    {
      "as": "introduced",
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "A bill to establish a demonstration project to increase access to biosimilar biological products under the Medicare program.",
      "type": "official"
    },
    {
      "as": "introduced",
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "Increasing Access to Biosimilars Act of 2021",
      "type": "short"
    }
  ],
  "updated_at": "2023-03-08T20:12:35Z",
  "url": "https://www.govinfo.gov/bulkdata/BILLSTATUS/117/s/BILLSTATUS-117s1427.xml"
}